Solgenics Limited Result of Meeting (8608A)
2023年5月26日 - 11:19PM
RNSを含む英国規制内ニュース (英語)
TIDMSGN
RNS Number : 8608A
Solgenics Limited
26 May 2023
News Release
Result of GM
26 May 2023: Solgenics Limited ("Solgenics" or the "Company")
(AIM: SGN) announces that, at the General Meeting ("GM") of the
Company held today, the special resolutions to approve the
cancellation of shares from AIM and to amend the Articles of
Association were duly passed on a poll. The Company received
authorised votes from 317,857,465 shares, representing 56% of the
Company's shares in issue. Votes in support of both resolutions
were 98% and 97% respectively.
The last day of dealings in the Company's Ordinary Shares on AIM
will be Tuesday 6 June 2023 and the Cancellation will become
effective at 7.00 a.m. on Wednesday 7 June 2023, subject to a
dealing notice, as defined in the AIM Rules for Companies, being
issued.
Enquiries
For further information please visit www.solgenics.com or
contact:
Solgenics: Hanno Pengilly +27 (0) 71 362 3566
Liberum Capital Limited: Scott Mathieson, Edward Thomas, +44 (0) 20 3100
NOMAD & Joint Broker Kane Collings 2000
Novum Securities
Limited +44 (0) 20 7399
Joint Broker Colin Rowbury 9427
Pimlico Advisory
Ltd +44 (0) 777 56 55
Investor Relations Elizabeth Johnson 927
About Solgenics
Solgenics is an African renewable energy development company
focused on the development of a 300MW solar PV plus BESS power
project in the Tete Province in northern Mozambique (the "Tete
Solar Project").
It is the intention that the Tete Solar Project will connect to
the Mozambique grid with target power offtakers in Mozambique and
the Southern African Power Pool ("SAPP").
The Tete Solar Project takes full advantage of Mozambique's
leading sustainable energy resources and is fully aligned with
Government's objective to become a champion for energy transition
impacting all Southern Africa.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ROMFLFLSEDIRFIV
(END) Dow Jones Newswires
May 26, 2023 10:19 ET (14:19 GMT)
Solgenics (LSE:SGN)
過去 株価チャート
から 11 2024 まで 12 2024
Solgenics (LSE:SGN)
過去 株価チャート
から 12 2023 まで 12 2024